Healthcare professionals' trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now ...

Discover new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for ...

Research uncovers the impact of the airway microbiome on severe asthma, particularly neutrophilic asthma, linking specific ...

Discover findings from ERS 2024 showing that continuing anticoagulation after the acute phase of COVID-19 reduces the risk of ...

A major review finds no strong evidence linking mobile phone use to an increased risk of cancer, including brain tumours.

A new study presented at IDWeek 2024 reveals that race and socioeconomic vulnerabilities significantly impact vaccine uptake ...

FDA approves Optune Lua, a wearable device for metastatic NSCLC, offering a new treatment option after platinum-based ...

Four genes with significant effects on the timing of menopause have been uncovered by a recent study offering insights into ...

Research suggests that fertility preservation is equally effective in testosterone-exposed and testosterone-naïve individuals ...

A South Korean study highlights the increased cancer risks, including biliary, pancreatic, and thyroid cancers, in patients ...

New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...

The U.S. FDA has approved the first 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease.